Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression

  • Authors:
    • Akihiro Toyoda
    • Hidetada Kawana
    • Kouji Azuhata
    • Jianyong Yu
    • Aya Omata
    • Hirohisa Kishi
    • Morihiro Higashi
    • Kenichi Harigaya
  • View Affiliations

  • Published online on: January 1, 2009     https://doi.org/10.3892/ijo_00000128
  • Pages:53-60
0

Abstract

The human ortholog of mammalian enabled (hMena), a family of enabled/vasodilator-stimulated phosphoprotein (Ena/VASP), is an actin regulatory protein involved in the regulation of cell motility. Increasing evidence suggests that hMena over-expression is involved in human breast cancers, whereas the significance of hMena expression in colorectal carcinomas remains to be elucidated. In this study, we assessed the relative mRNA level of hMena using real-time PCR, showing that there is a statistically significant increase of hMena transcripts in matched human colorectal carcinomas and adjacent non-neoplastic colorectal epithelium (n=6, P=0.046). We also performed immunohistochemical analysis of the expression of hMena protein in 50 cases of paraffin-embedded archival colorectal tissues, and found that an elevated hMena expression is correlated to the cases with advanced TNM stages of colorectal carcinomas (P<0.001). On further inspection of immunohistochemical features of each specimen, we observed intensified hMena staining in the invasive front of colorectal carcinomas, especially in tumor budding, a transition from glandular structure to single or small clusters of cells at the invasive front. We demonstrated that there was a significantly increased hMena staining in the tumor budding as compared with more morphologically-differentiated areas of colorectal carcinomas, indicating that hMena over-expression may have a role in the initial steps of tumor invasion from primary sites. We performed in vitro motility assays to show that transient hMena transfection markedly enhanced the chemotactic/chemokinetic activity of HeLaS3 cells (P<0.001). Taken together, these results suggest that hMena over-expression is implicated in the progression of colorectal carcinomas by positively affecting the migratory phenotype of cancer cells.

Related Articles

Journal Cover

January 2009
Volume 34 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

2015 Impact Factor: 3.018
Ranked #30/211 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Toyoda, A., Kawana, H., Azuhata, K., Yu, J., Omata, A., Kishi, H. ... Harigaya, K. (2009). Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. International Journal of Oncology, 34, 53-60. https://doi.org/10.3892/ijo_00000128
MLA
Toyoda, A., Kawana, H., Azuhata, K., Yu, J., Omata, A., Kishi, H., Higashi, M., Harigaya, K."Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression". International Journal of Oncology 34.1 (2009): 53-60.
Chicago
Toyoda, A., Kawana, H., Azuhata, K., Yu, J., Omata, A., Kishi, H., Higashi, M., Harigaya, K."Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression". International Journal of Oncology 34, no. 1 (2009): 53-60. https://doi.org/10.3892/ijo_00000128